| Withdrawn | Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC Microsatellite-stable Colorectal Cancer | Phase 2 | 2020-10-01 |
| Active Not Recruiting | A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma Advanced Renal Cell Carcinoma | Phase 1 | 2020-08-05 |
| Withdrawn | Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza Influenza | Phase 2 | 2020-04-03 |
| Completed | IPH5201 as Monotherapy or in Combination With Durvalumab +/- Oleclumab in Subjects With Advanced Solid Tumors. Advanced Solid Tumors | Phase 1 | 2020-03-03 |
| Completed | A Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-10-24 |
| Completed | A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide Type 2 Diabetes Mellitus | Phase 1 | 2019-09-27 |
| Completed | A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) | Phase 2 | 2019-09-23 |
| Active Not Recruiting | COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy i Metastatic Microsatellite-stable Colorectal Cancer | Phase 1 / Phase 2 | 2019-09-13 |
| Completed | A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid T Solid Tumors, Cancer | Phase 1 | 2019-05-08 |
| Completed | Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer Resectable, Early-stage, NSCLC | Phase 2 | 2019-03-08 |
| Completed | A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 D Type 2 Diabetes Mellitus | Phase 2 | 2019-01-07 |
| Completed | A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors Non Small Cell Lung Cancer Squamous (NSCLC-Sq), Head and Neck Squamous Cell Carcinoma (HNSCC), Small Cell Lung Cancer (SCLC) | Phase 1 | 2018-12-20 |
| Completed | Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC Stage III Non-small Cell Lung Cancer, Unresectable | Phase 2 | 2018-12-19 |
| Completed | Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus Atherosclerosis, Cardiovascular Disease | Phase 1 | 2018-09-28 |
| Completed | A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus, Type II, Obesity | Phase 2 | 2018-09-26 |
| Completed | A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese Participants Obesity | Phase 1 | 2018-08-14 |
| Completed | A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems a Type II Diabetes Mellitus, Renal Insufficiency | Phase 2 | 2018-06-29 |
| Completed | MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. Carcinoma, Metastatic Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2018-06-21 |
| Completed | D2560C00015 FluMist Annual Safety Study 2018 Influenza, Healthy | Phase 4 | 2018-06-06 |
| Completed | A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction ST Elevation Myocardial Infarction | Phase 2 | 2018-06-05 |
| Completed | A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects Type 2 Diabetes Mellitus | Phase 2 | 2018-05-31 |
| Completed | MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma | Phase 1 | 2018-05-08 |
| Active Not Recruiting | Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2018-05-08 |
| Completed | Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Type 2 Diabetes Mellitus | Phase 2 | 2018-05-08 |
| Active Not Recruiting | A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors Selected Advanced Solid Tumors | Phase 1 | 2018-04-24 |
| Completed | A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Ch Safety, Healthy Subjects | Phase 1 | 2018-01-05 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stabl Stable Coronary Heart Disease | Phase 2 | 2017-12-13 |
| Terminated | A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Healthy Volunteers | Phase 1 | 2017-12-04 |
| Completed | A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI038 Type 2 Diabetes Mellitus | Phase 1 | 2017-11-30 |
| Completed | Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI03 Healthy Volunteers | Phase 1 | 2017-11-27 |
| Completed | A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects Renal Insufficiency | Phase 1 | 2017-10-27 |
| Completed | A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. Type 2 Diabetes Mellitus | Phase 2 | 2017-09-04 |
| Withdrawn | Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza - Type A Strains | Phase 2 | 2017-07-24 |
| Completed | Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Rec Head and Neck Cancer, Human Papilloma Virus | Phase 1 / Phase 2 | 2017-06-26 |
| Completed | Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season Influenza, Healthy | Phase 4 | 2017-05-30 |
| Completed | Safety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese Pa Part I (SAD) - Healthy Participants, Part II (MAD) - Chronic Obstructive Pulmonary Disease, Part III (J-SD) - Healthy Japanese Participants | Phase 1 | 2017-05-15 |
| Completed | Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of A Influenza, Healthy | Phase 4 | 2017-05-08 |
| Completed | A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malign Acute Myeloid Leukemia, Multiple Myeloma, Diffuse Large B-cell Lymphoma | Phase 1 | 2017-03-29 |
| Completed | MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel. Advanced Solid Tumors | Phase 1 | 2017-03-21 |
| Completed | Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease Atherosclerosis, Cardiovascular Disease | Phase 2 | 2017-01-23 |
| Completed | Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884 Healthy Volunteers | Phase 1 | 2017-01-17 |
| Completed | A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer Metastatic Castration Resistant Prostate Cancer | Phase 1 | 2017-01-06 |
| Completed | A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in H Respiratory Syncytial Virus Infections | Phase 2 | 2016-11-03 |
| Completed | Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2016-08-09 |
| Completed | MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBC Diffuse Large B-Cell Lymphoma | Phase 1 | 2016-07-13 |
| Completed | Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season Influenza, Healthy | Phase 4 | 2016-05-02 |
| Completed | A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Sol Select Advanced Solid Tumors | Phase 1 | 2016-03-30 |
| Completed | Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects Pseudomonas Aeruginosa | Phase 2 | 2016-03-25 |
| Active Not Recruiting | A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2016-02-22 |
| Completed | Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects Safety, Healthy Subjects | Phase 1 | 2016-02-18 |
| Completed | A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Ove Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | 2015-12-09 |
| Completed | A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza Influenza | Phase 1 / Phase 2 | 2015-12-07 |
| Completed | To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Coronary Artery Disease | Phase 2 | 2015-12-03 |
| Completed | A Study in Adult Subjects With Select Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2015-11-09 |
| Terminated | A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Solid Tumors, CTCL, Cancer | Phase 1 | 2015-11-04 |
| Active Not Recruiting | A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizum Hepatocellular Carcinoma | Phase 2 | 2015-10-19 |
| Completed | A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmac Type 2 Diabetes | Phase 1 | 2015-10-07 |
| Terminated | A Study to Evaluate the Efficacy of MEDI7510 in Older Adults Respiratory Syncytial Virus | Phase 2 | 2015-09-29 |
| Completed | A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors. HER2 Expressing Breast or Gastric/Stomach Cancers | Phase 1 | 2015-09-23 |
| Completed | A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma Asthma | Phase 1 | 2015-09-10 |
| Completed | Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2015-08-15 |
| Completed | MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors. Solid Tumors | Phase 1 | 2015-07-24 |
| Completed | A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in P Primary Sjögren's Syndrome | Phase 2 | 2015-06-08 |
| Completed | Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season Influenza, Healthy | Phase 4 | 2015-06-01 |
| Completed | N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders | Phase 2 / Phase 3 | 2015-04-01 |
| Completed | A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adeno Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 1 / Phase 2 | 2015-03-31 |
| Completed | A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2015-03-02 |
| Completed | A Study to Assess the Safety of MEDI7836 in Healthy Adults. Healthy Adults | Phase 1 | 2015-03-01 |
| Completed | A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2015-02-01 |
| Completed | Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2015-01-23 |
| Completed | A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tole Respiratory Syncytial Virus | Phase 1 | 2015-01-13 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults Respiratory Syncytial Virus (RSV) | Phase 1 | 2015-01-05 |
| Completed | Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Ad Influenza | Phase 1 | 2015-01-01 |
| Completed | Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Relapsed/Refractory Aggressive B-cell Lymphomas | Phase 1 / Phase 2 | 2014-12-01 |
| Completed | A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab i Squamous Cell Carcinoma of the Head and Neck | Phase 1 | 2014-10-15 |
| Completed | A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2014-10-13 |
| Completed | Study of the Efficacy and Safety of MEDI4893 Staphylococcus Aureus Pneumonia | Phase 2 | 2014-10-10 |
| Completed | A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Adva Recurrent or Metastatic Solid Tumors | Phase 1 | 2014-09-15 |
| Completed | Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adul MEDI3902 for Prevention of P. Aeruginosa Pneumonia | Phase 1 | 2014-09-04 |
| Terminated | A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monocl Advanced Solid Tumors, Aggressive B-cell Lymphomas | Phase 1 / Phase 2 | 2014-08-13 |
| Terminated | Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic B-Cell Pediatric ALL | Phase 2 | 2014-08-01 |
| Completed | A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese Subjects Healthy Volunteers | Phase 1 | 2014-07-01 |
| Completed | Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Art Rheumatoid Arthritis | Phase 1 | 2014-06-01 |
| Completed | Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults Healthy Volunteer | Phase 1 | 2014-05-27 |
| Completed | Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome Myelodysplastic Syndrome | Phase 1 | 2014-05-20 |
| Completed | A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combinati Select Advanced Malignancies, Kidney Cancer, Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | 2014-05-19 |
| Completed | A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults Respiratory Syncytial Virus Infections | Phase 1 | 2014-04-01 |
| Completed | A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults Respiratory Syncytial Virus (RSV) | Phase 1 | 2014-04-01 |
| Completed | MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC). Carcinoma, Non-Small-Cell Lung | Phase 1 | 2014-03-24 |
| Completed | A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers Asthma, Healthy Subjects or Volunteers | Phase 1 | 2014-03-19 |
| Completed | Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age Observation Safety | — | 2014-01-01 |
| Completed | Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib A Melanoma | Phase 1 | 2013-12-20 |
| Completed | A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Sub Advanced Malignancies | Phase 1 | 2013-12-19 |
| Completed | Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled Asthma | Phase 2 | 2013-12-13 |
| Terminated | A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Sub Influenza Vaccine Effectiveness | — | 2013-12-02 |
| Completed | A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Ca NSCLC, Non-small Cell Lung Cancer, Lung Cancer | Phase 1 | 2013-10-25 |
| Active Not Recruiting | Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesot Unresectable Pleural or Peritoneal Malignant Mesothelioma | Phase 2 | 2013-05-17 |
| Completed | Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults Influenza, Healthy | Phase 4 | 2013-05-01 |
| Completed | Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia Leukemia, Hairy Cell | Phase 3 | 2013-04-29 |
| Completed | Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthriti Rheumatoid Arthritis | Phase 1 | 2013-04-01 |
| Completed | An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults Lupus Erythematosus, Systemic | Phase 2 | 2013-03-28 |
| Completed | A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2013-03-01 |
| Terminated | A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2013-01-28 |
| Completed | A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjec Staphylococcus Aureus | Phase 1 | 2013-01-01 |
| Terminated | A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pu Idiopathic Pulmonary Fibrosis | Phase 2 | 2012-10-01 |
| Completed | A Phase 1/2 Study to Evaluate MEDI4736 Advanced Solid Tumors | Phase 1 / Phase 2 | 2012-09-05 |
| Completed | A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2012-08-01 |
| Completed | A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With Asthma | Phase 1 | 2012-06-01 |
| Completed | A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults Influenza | Phase 4 | 2012-05-01 |
| Completed | Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Scle Multiple Sclerosis, Relapsing Forms | Phase 1 | 2012-04-24 |
| Completed | A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumor Solid Tumors | Phase 1 | 2012-04-01 |
| Completed | Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Art Coronary Artery Disease, Atherosclerosis | Phase 1 | 2012-03-01 |
| Completed | MEDI-557 Adult Dosing Respiratory Syncytial Virus | Phase 1 | 2012-03-01 |
| Completed | A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Diffuse Large B-Cell Lymphoma | Phase 2 | 2012-02-27 |
| Completed | A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Chronic Lymphocytic Leukemia (CLL) | Phase 2 | 2012-02-07 |
| Completed | MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC. Unresectable or Metastatic Hepatocellular Carcinoma (HCC) | Phase 1 | 2012-01-17 |
| Completed | A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers Healthy Subjects | Phase 1 | 2012-01-01 |
| Completed | A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2012-01-01 |
| Completed | A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 Allergic Asthma, Atopic Dermatitis, Allergic Rhinitis | Phase 1 | 2012-01-01 |
| Completed | A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease | Phase 2 | 2011-11-01 |
| Terminated | Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) RSV Infection | Phase 1 | 2011-10-20 |
| Completed | A Safety and Efficacy Study of Tralokinumab in Adults With Asthma Asthma | Phase 2 | 2011-08-01 |
| Completed | Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer | Phase 2 | 2011-06-13 |
| Completed | A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations Chronic Obstructive Pulmonary Disease | — | 2011-04-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2011-03-31 |
| Completed | Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer Cancer | Phase 1 | 2011-03-01 |
| Completed | A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid Arthritis Arthritis | — | 2011-03-01 |
| Completed | A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease | Phase 1 | 2011-03-01 |
| Terminated | A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease | — | 2011-02-01 |
| Completed | A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthm Asthma | — | 2011-01-01 |
| Completed | A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme Glioblastoma Multiforme | Phase 2 | 2011-01-01 |
| Terminated | A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Canc Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2010-12-16 |
| Completed | A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas Gastrointestinal Adenocarcinomas | Phase 1 | 2010-12-01 |
| Completed | Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma Asthma | Phase 2 | 2010-12-01 |
| Completed | A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD Pulmonary Disease, Chronic Obstructive | Phase 2 | 2010-11-01 |
| Completed | A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors Advanced Solid Tumors, Advanced Recurrent Ovarian Tumors | Phase 1 | 2010-10-01 |
| Withdrawn | A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in I Wheezing | Phase 3 | 2010-10-01 |
| Completed | A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus o Systemic Lupus Erythematosus | Phase 2 | 2010-08-01 |
| Completed | An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure | — | 2010-07-01 |
| Terminated | A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 1 | 2010-05-01 |
| Completed | A Clinical Study to Assess the Safety of a New Influenza Vaccine Healthy | Phase 4 | 2010-05-01 |
| Completed | A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies B-cell Malignancies, Cancer | Phase 1 / Phase 2 | 2010-04-16 |
| Completed | A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese Subjects Healthy | Phase 1 | 2010-04-01 |
| Completed | A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children Healthy or Stable Chronic Illness | Phase 3 | 2010-03-01 |
| Completed | A Study of the Safety and Tolerability of MEDI-551 in Scleroderma Scleroderma | Phase 1 | 2010-03-01 |
| Completed | Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL o Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2010-02-15 |
| Completed | A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2010-01-05 |
| Completed | A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults Asthma | Phase 2 | 2009-12-01 |
| Completed | An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants Healthy | — | 2009-09-01 |
| Completed | A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma Scleroderma | Phase 1 | 2009-09-01 |
| Completed | A Study to Evaluate the Safety of H1N1 Monovalent Vaccine (MEDI3414) in Healthy Adults Healthy | Phase 4 | 2009-08-01 |
| Completed | A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age Healthy or Stable Underlying Chronic Medical Condition | Phase 3 | 2009-08-01 |
| Completed | A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age Influenza | Phase 4 | 2009-08-01 |
| Terminated | Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects Cancer | Phase 1 | 2009-08-01 |
| Completed | Study to Evaluate the Safety and Efficacy of CAT-354 Asthma | Phase 2 | 2009-06-01 |
| Completed | A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine Healthy | Phase 4 | 2009-05-01 |
| Completed | A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects W Cancer | Phase 1 | 2009-03-09 |
| Completed | A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-5 Cancer | Phase 1 | 2009-03-02 |
| Completed | A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age Healthy or Stable Underlying Chronic Medical Condition | Phase 2 / Phase 3 | 2009-03-01 |
| Completed | A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563). Asthma | Phase 2 | 2009-02-02 |
| Completed | A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With Asthma Asthma | Phase 2 | 2008-11-14 |
| Completed | Respiratory Events Among Premature Infants Respiratory Syncytial Virus | — | 2008-11-01 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month- Healthy | Phase 1 / Phase 2 | 2008-10-01 |
| Completed | CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma | Phase 1 | 2008-09-01 |
| Completed | Assessing Choice in the Employer Setting (ACES) Study Healthy | — | 2008-09-01 |
| Completed | A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus Lupus Erythematosus, Systemic, Lupus | Phase 2 | 2008-07-01 |
| Completed | A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Agai Healthy | Phase 1 / Phase 2 | 2008-06-01 |
| Withdrawn | A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MED Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2008-06-01 |
| Completed | A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine Influenza | Phase 4 | 2008-06-01 |
| Completed | A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354 Asthma, Healthy | Phase 1 | 2008-04-11 |
| Completed | A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis DERMATOMYOSITIS OR POLYMYOSITIS | Phase 1 | 2008-04-01 |
| Withdrawn | A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2008-04-01 |
| Terminated | A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With As Asthma | Phase 2 | 2008-03-01 |
| Completed | A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma Asthma | Phase 1 | 2008-01-01 |
| Terminated | A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With Asthma Asthma | Phase 2 | 2008-01-01 |
| Completed | A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Healthy | Phase 1 | 2007-12-01 |
| Terminated | A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Month Healthy | Phase 1 / Phase 2 | 2007-10-01 |
| Completed | A Post Marking Study to Evaluate the Safety of FluMist in Children Healthy | — | 2007-10-01 |
| Completed | A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children Asthma, Wheezing, Immunosuppression | — | 2007-10-01 |
| Withdrawn | A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma Lymphoma, B-Cell, Lymphoma, Non-Hodgkin | Phase 1 | 2007-09-01 |
| Completed | A Study to Describe Pediatric Influenza Vaccine Coverage Healthy | — | 2007-08-01 |
| Terminated | A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) Lymphoma | Phase 1 | 2007-08-01 |
| Completed | A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multipl Asthma | Phase 2 | 2007-07-01 |
| Terminated | A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528 Asthma | Phase 2 | 2007-07-01 |
| Completed | Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age Respiratory Viral Infections, Respiratory Syncytial Virus Infections, Parainfluenza Virus 3, Human | Phase 1 | 2007-07-01 |
| Completed | A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Sys Lupus | Phase 1 | 2007-06-01 |
| Completed | A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia Hairy Cell Leukemia | Phase 1 | 2007-05-10 |
| Completed | A Phase 2 Study to Evaluate Immune Responses of FluMist® Influenza Vaccine | Phase 2 | 2007-05-01 |
| Completed | A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults Healthy | Phase 2 | 2007-05-01 |
| Terminated | A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Vi Participants Less Than 12 Months of Age With RSV Illness | Phase 2 | 2007-03-20 |
| Terminated | A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia Leukemia, Lymphoma, Chronic Lymphocytic, Leukemia, Prolymphocytic Leukemia, Small, Lymphocytic Lymphoma, Moxetumomab Pasudotox | Phase 1 | 2007-03-07 |
| Completed | A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545 Chronic Plaque Psoriasis | Phase 1 | 2007-02-01 |
| Completed | A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With R RSV Illness in ≤12 Months of Participants | N/A | 2007-01-10 |
| Completed | A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma Asthma | Phase 2 | 2006-11-01 |
| Completed | A Sequential Dose-Escalation Study in Subjects With Mild Asthma Asthma | Phase 1 | 2006-11-01 |
| Completed | Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants Respiratory Syncytial Virus Infections | — | 2006-10-01 |
| Terminated | A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Mode Moderate Asthma | Phase 1 | 2006-09-29 |
| Completed | An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants Respiratory Infections, Bronchiolitis, Pneumonia | — | 2006-09-01 |
| Completed | Study To Evaluate the Safety of Bivalent Vaccine Healthy | Phase 3 | 2006-06-01 |
| Completed | Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza V Healthy | Phase 1 | 2006-06-01 |
| Completed | A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants a Healthy | Phase 2 | 2006-05-01 |
| Completed | Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Vi Respiratory Syncytial Virus Infections, Chronic Lung Disease and <= 24 Months of Age or, Premature With Gestational Age <=35 Weeks and <=6 Months of Age | Phase 2 | 2006-04-01 |
| Completed | Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) Lupus | Phase 1 | 2006-03-01 |
| Completed | Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Syn Chronic Lung Disease | Phase 4 | 2005-10-01 |
| Completed | A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease Congenital Heart Disease | Phase 2 | 2005-10-01 |
| Completed | Safety Study to Evaluate FluMist in Immunocompromised Children Cancer | Phase 1 | 2005-08-01 |
| Completed | Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults Healthy, Influenza | Phase 3 | 2005-07-01 |
| Completed | BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, o Leukemia, Lymphoma | Phase 1 | 2005-06-01 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous A Healthy | Phase 1 | 2005-06-01 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Motavizumab Administration for a Second Season for RSV Prophylaxis | Phase 1 / Phase 2 | 2005-05-01 |
| Completed | Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV Influenza | Phase 2 | 2005-05-01 |
| Completed | Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Maligna Malignant Melanoma | Phase 1 | 2005-05-01 |
| Completed | Study to Evaluate MEDI-534 in Healthy Adults Respiratory Syncytial Virus Infections, Parainfluenza Infections | — | 2005-04-01 |
| Terminated | Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia Lymphoma, Leukemia, Cancer | Phase 1 | 2005-02-01 |
| Completed | MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American In Healthy | Phase 3 | 2004-11-15 |
| Completed | Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in Hi Respiratory Syncytial Virus Infections | Phase 3 | 2004-11-01 |
| Completed | Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Childr Influenza | Phase 3 | 2004-10-01 |
| Completed | Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program Influenza | Phase 4 | 2004-10-01 |
| Completed | Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528 in Healthy Adult V Asthma | Phase 1 | 2004-08-01 |
| Completed | Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults Influenza | Phase 3 | 2004-08-01 |
| Completed | Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants Healthy | Phase 3 | 2004-07-01 |
| Completed | Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients Leukemia, Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2004-07-01 |
| Completed | Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Ye Influenza | Phase 4 | 2004-06-01 |
| Terminated | Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease Lymphoproliferative Disorders | Phase 1 | 2004-04-01 |
| Completed | Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV I Respiratory Syncytial Virus Prophylaxis | Phase 1 | 2004-03-01 |
| Completed | Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Follow Respiratory Syncytial Virus Infections | Phase 1 / Phase 2 | 2004-02-01 |
| Suspended | BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Ho Leukemia, Lymphoma | Phase 1 | 2004-01-01 |
| Completed | Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk Severe Respiratory Disease | — | 2003-12-01 |
| Completed | MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer Prostate Cancer | Phase 2 | 2003-12-01 |
| Completed | Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis Psoriasis | Phase 2 | 2003-12-01 |
| Completed | Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults Respiratory Syncytial Virus Infections | Phase 1 | 2003-11-01 |
| Completed | Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis i Esophagitis, Pneumonitis, Non-Small Cell Lung Carcinoma | Phase 2 | 2003-11-01 |
| Completed | A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults Healthy | — | 2003-10-01 |
| Completed | BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia Leukemia | Phase 2 | 2003-10-01 |
| Completed | Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Art Rheumatoid Arthritis | Phase 2 | 2003-09-01 |
| Completed | Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma Melanoma, Malignant Metastatic Melanoma | Phase 2 | 2003-08-01 |
| Completed | A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children Influenza | Phase 2 | 2003-06-01 |
| Completed | Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Vir Asthma | Phase 3 | 2002-10-01 |
| Completed | Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Viru Respiratory Tract Infections | Phase 3 | 2002-10-01 |
| Completed | Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulati Influenza | Phase 2 | 2002-10-01 |
| Completed | A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and -Unhealthy Children With a History of Prematurity | Phase 2 | 2002-09-01 |
| Completed | Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024) Influenza | Phase 3 | 2002-08-01 |
| Completed | Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults Healthy Japanese Male Adults | Phase 1 | 2002-08-01 |
| Completed | Long-Term Follow-Up Study of Psoriasis Patients Psoriasis | — | 2002-08-01 |
| Completed | A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Inf Healthy | Phase 1 | 2002-05-01 |
| Completed | Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza | Phase 3 | 2002-03-01 |
| Completed | Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children. Healthy | Phase 3 | 2002-03-01 |
| Completed | Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formul Healthy | Phase 3 | 2002-02-01 |
| Completed | Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine. Influenza | Phase 2 | 2001-09-01 |
| Completed | A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis Plaque Psoriasis | Phase 2 | 2001-09-01 |
| Completed | Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children. Influenza | Phase 3 | 2001-09-01 |
| Completed | Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Influenza | Phase 2 | 2001-09-01 |
| Completed | Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T) Influenza | Phase 2 | 2001-09-01 |
| Completed | Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer Cancer | Phase 1 / Phase 2 | 2001-07-01 |
| Completed | Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in He Influenza | Phase 2 | 2001-07-01 |
| Completed | Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T) Influenza | Phase 3 | 2001-04-01 |
| Completed | Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAI Influenza | Phase 3 | 2001-04-01 |
| Completed | Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors Cancer | Phase 1 | 2001-03-01 |
| Completed | Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis Psoriasis | Phase 2 | 2001-03-01 |
| Completed | Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, L Influenza | Phase 3 | 2000-12-01 |
| Completed | Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Influenza | Phase 3 | 2000-11-01 |
| Completed | Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Healthy | Phase 2 | 2000-10-01 |
| Completed | Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adap Healthy | Phase 3 | 2000-09-01 |
| Completed | Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adap Influenza | Phase 3 | 2000-09-01 |
| Completed | Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV Influenza | Phase 3 | 1999-11-01 |
| Completed | Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 Healthy | Phase 1 / Phase 2 | 1999-11-01 |
| Completed | Study of MEDI 507 in the Treatment of Pediatric Patients Graft Versus Host Disease | Phase 1 | 1999-09-01 |
| Completed | Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Gra Graft-Versus-Host Disease | Phase 1 | 1999-01-01 |
| Completed | Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease Cancer, Graft-Versus-Host Disease | Phase 1 | 1998-05-01 |
| Completed | A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection Kidney Diseases | Phase 1 | 1997-02-01 |